NCT07064538View on ClinicalTrials.gov

Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits

NAEnrolling by invitationINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

August 31, 2026

Conditions
ASDAutismAutistic Disorders Spectrum
Interventions
DIETARY_SUPPLEMENT

Neuralli® MP

Neuralli® MP containing 60 billion CFU (administered as two capsules per day)

Trial Locations (1)

Unknown

Mackay Memorial Hospital, Taipei

All Listed Sponsors
collaborator

Bened Biomedical Co., Ltd.

INDUSTRY

lead

Mackay Memorial Hospital

OTHER